Loading
HI
HilleVax, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Frazier Life Sciences X, L.P., was filed 08 Apr 2024.
HilleVax, Inc.: what insiders have been doing
HilleVax, Inc., classified in the Technology sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). The past year has been quiet: not a single insider filing for HilleVax, Inc. The previous disclosure was published on 19 September 2025.
The full history, which starts in 2022, counts 3 purchases against 32 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Hanza AB and Lime Technologies AB (publ). These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
66
Thresholds
n/a
Buy Volume
€29M
3 ops. · all time
Sell Volume
€909M
32 ops. · all time
Who traded when
BuySaleRobert Hershberg2 sales
Shane Maltbie2 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended December 2024 · cache
Income statement
Net income-131.1M
Last declaration on 19 September 2025
Declarations66 total
6,724,000 shares@ US$1.95100.0% of flowCommon StockSEC:0001395064-25-000140:0
17,199 shares@ US$1.950.0% of flowCommon StockSEC:0001790879-25-000007:1
8,535,337 shares@ US$1.9528.4% of flowCommon StockSEC:0001790879-25-000007:0
59,224 sharesCommon StockSEC:0001193125-25-206259:0
1,101,498 sharesCommon StockSEC:0001193125-25-206257:0
17,199 sharesCommon StockSEC:0001193125-25-206256:0
17,199 sharesCommon StockSEC:0001193125-25-206254:0
59,224 sharesCommon StockSEC:0001193125-25-206253:0
17,199 sharesCommon StockSEC:0001193125-25-206252:0
698,171 sharesCommon StockSEC:0001193125-25-206251:0
59,224 sharesCommon StockSEC:0001193125-25-206249:0
83,738 sharesCommon StockSEC:0001193125-25-206248:0
17,199 shares0Common StockSEC:0000950170-25-090020:0
17,199 shares0Common StockSEC:0000950170-25-090011:0
17,199 shares0Common StockSEC:0000950170-25-089971:0
17,199 shares0Common StockSEC:0000950170-25-089966:0
17,199 shares0Common StockSEC:0000950170-25-089962:0
17,199 shares0Common StockSEC:0000950170-25-089961:0
17,199 shares0Common StockSEC:0000950170-25-089958:0
17,199 shares0Common StockSEC:0000950170-25-089951:0
4,345 shares@ US$1.7611.6% of flowCommon StockSEC:0000950170-25-018821:1
11,901 shares@ US$1.769.8% of flowCommon StockSEC:0000950170-25-018822:1
3,946 shares@ US$1.8912.7% of flowCommon StockSEC:0000950170-25-018821:0
14,634 shares@ US$1.8914.3% of flowCommon StockSEC:0000950170-25-018822:0
6,000 shares@ US$14.210.0% of flowCommon StockSEC:0000950170-24-063631:1
25 of 66 declarations
About HilleVax, Inc.
HilleVax, Inc. is a company focused on vaccine development. It is listed on the XNAS market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
